Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Abbott

Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit

Metabolic health is all the rage, helped by the advent of weight-loss drugs and continuous glucose monitors. Can they change disease forever?

Investors Business Daily

I tried Abbott’s new CGM Lingo for two weeks, and here’s what I learned

5 things you need to know about Lingo, the new smart continuous glucose monitor.

TechRadar

Why aren't The Conners, Not Dead Yet and Abbott Elementary new tonight, April 3?

For the second week in a row, The Conners, Not Dead Yet and Abbott Elementary are airing reruns in place of new episodes. Here's what we know.

WhatToWatch

From analysis to the latest developments in health,
read the most diverse news in one place.

Abbott's Heart Valve Repair Device Receives US Approval

Abbott's ABBOTT-HEART device gains US approval, offering minimally invasive heart valve repair solution, revolutionizing heart care.

Top News

3 Passive Income Stocks To Scoop Up Now

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

Barchart

U.S. govt protected baby formula makers

The U.S. government repeatedly used its muscle to advance the interests of large baby formula companies

Salon

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst

Abbott stock tumbled to a month-low Friday after an Illinois jury ordered Reckitt Benckiser to pay $60 million in an infant formula lawsuit.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Continuous glucose monitors – health fad or the future of wellbeing?

Over the past couple of years, interest in direct-to-consumer applications for continuous glucose monitoring has spiked, but not every expert is convinced these medical devices have a place in the arms of regular, non-diabetic folk.

TechRadar

SECURE 2.0 Act Now Helps Lighten the Burden of Student Loans

Employers can attract talented employees with a new benefit: a matching contribution to an employees’ 401(k) when they make payments on their student debt.

Kiplinger

Dexcom Breaks Out As FDA Clears It To Enter A New Market: Obesity

Dexcom stock popped Wednesday after the FDA cleared its newest body-worn glucose monitor for people who don't require insulin treatment.

Investors Business Daily

10 Best Technology Brands At CES 2024

The final list is not just a win for consumers on the lookout for groundbreaking tech but also serves as an eye-opener to investors searching for scalable tech solutions poised for global impact.

International Business Times

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times

Abbott Laboratories Reports Strong Earnings Despite Recent Challenges

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

Top News

Abbott's 2024 Earnings Forecast Hits Below Estimates, Shares Decline

Abbott predicts lower-than-expected earnings for 2024, causing a decline in its shares. Investors are disappointed with the forecast.

Investors Business Daily

Abbott Labs Skids Within A Saucer Base Despite 'Solid Results'

Abbott's earnings guidance slightly missed expectations at the midpoint Wednesday, and ABT stock fell within a saucer base.

Get all your
news in one place.

100’s of premium titles.
One news app.

Latin Times

Four Measures Taken by New York City's Government to Address the Migrant Crisis

Around 170,000 migrants have arrived in New York City since 2022, putting its shelter system and financial situation under pressure

The Independent UK

Real-time glucose monitoring wearable launches in the UK – here’s how it works

The Abbott Lingo analyses a wearer’s glucose spikes and falls and offers personalised habit suggestions and coaching in response

Barchart

100 Years of Paying Dividends: Why You Need This Healthcare Stock

Dividend growth investors love this boring healthcare stock for three reasons: Growth, financial stability, and 100 years of paying dividends.

The Independent UK

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

Investors Business Daily

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Investors Business Daily

Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review

The major indexes saw significant loses as Treasury yields soared. Tesla tumbled on earnings while Nvidia fell on fresh China chip curbs.

Investors Business Daily

Abbott Shrugs Off 'Tizzy' Over Weight-Loss Drugs, Surging On Beat And Raise

Abbott stock popped Wednesday after shrugging off concerns that new diabetes and weight-loss drugs will undercut its diabetes devices.

1 2 3 4 5

People

Margaret Kaczor Andrew

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.